Silicone granulomas treated with etanercept

Archives of Dermatology

Volumn 141, Issue 9, 2005, Pages 1171-

  Rapaport, Marvin J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; SILICONE;

CELLULITIS; GRANULOMA; HUMAN; LIPOATROPHY; NOTE; OSTEOARTHRITIS; PRIORITY JOURNAL; SCAR;

EID: 25444489330     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.141.9.1171-a     Document Type: Note

References (7)

1. Pasternack F, Fox LP, Engler D. Silicone granulomas treated with etanercept. Arch Dermatol. 2005;141:13-15.
2. Benedetto AV, Lewis AT. Injecting 1000 centistoke liquid silicone with ease and precision. Dermatol Surg. 2003;29:211-214.
3. Duffy D. Silicone: a critical review. Adv Dermatol. 1990;5:93-110.
4. Rapaport MJ, Vinnik C, Zarem H. Injectable silicone: cause of facial nodules, cellulitis, ulceration, and migration. Aesthetic Plast Surg. 1996;20:267-276.
5. Rapaport MJ, Rapaport VH. Experience of dermatologists with injectable and implanted silicone: adverse effects 1997-2003. Available at: http://www .derm101.com. Accessed November 8, 2004.
6. Guttman C. Silicone granuloma management: TNF inhibitors may be as effective as intervention. Dermatology Times. May 2003:75-76.
7. Guttman C. Injectable silicone shows promise for treatment of HIVassociated facial lipoatrophy. Dermatology Times. January 2003:1.